| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-06 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |